We are live on ! Find out more
RBC

Romano Brothers & Co Portfolio holdings

AUM $994M
1-Year Est. Return 41.36%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+41.36%
3 Year Est. Return
+100.69%
5 Year Est. Return
10 Year Est. Return
AUM
$659M
AUM Growth
+$38.9M
Cap. Flow
-$14.2M
Cap. Flow %
-2.16%
Top 10 Hldgs %
19.91%
Holding
1,044
New
750
Increased
84
Reduced
162
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 17.54%
2 Technology 17.47%
3 Industrials 13.69%
4 Financials 7.94%
5 Consumer Discretionary 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALRM icon
1026
Alarm.com
ALRM
$2.73B
$396 ﹤0.01%
+8
New +$441
DJT icon
1027
Trump Media & Technology Group
DJT
$2.8B
$375 ﹤0.01%
+25
New +$488
CEVA icon
1028
CEVA Inc
CEVA
$1.01B
$358 ﹤0.01%
+14
New +$377
CWH icon
1029
Camping World
CWH
$685M
$357 ﹤0.01%
+16
New +$415
QDEL icon
1030
QuidelOrtho
QDEL
$1.17B
$343 ﹤0.01%
+4
New +$339
JMIA
1031
Jumia Technologies
JMIA
$760M
$321 ﹤0.01%
+100
New +$451
PUBM icon
1032
PubMatic
PUBM
$621M
$295 ﹤0.01%
+23
New +$361
MSTR icon
1033
Strategy Inc
MSTR
$35.2B
$283 ﹤0.01%
+20
New +$409
GRMN
1034
Garmin
GRMN
$58.5B
$277 ﹤0.01%
+3
New +$265
UPST icon
1035
Upstart Holdings
UPST
$2.95B
$251 ﹤0.01%
+19
New +$367
PZZA icon
1036
Papa John's
PZZA
$1.01B
$247 ﹤0.01%
+3
New +$236
DCPH
1037
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$246 ﹤0.01%
+15
New +$244
MQ icon
1038
Marqeta
MQ
$1.88B
$244 ﹤0.01%
+10
New +$273
MVIS icon
1039
Microvision
MVIS
$85.2M
$235 ﹤0.01%
+7
New +$325
AVIR icon
1040
Atea Pharmaceuticals
AVIR
$369M
$231 ﹤0.01%
+48
New +$243
SPIB icon
1041
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$223 ﹤0.01%
+7
New +$221
BMBL icon
1042
Bumble
BMBL
$404M
$211 ﹤0.01%
+10
New +$230
AYX
1043
DELISTED
Alteryx Inc
AYX
$203 ﹤0.01%
+4
New +$191
JEMD
1044
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
-27,500
Closed -$177K

Similar funds

Romano Brothers & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Romano Brothers & Co held 1,044 positions worth $659M, up 6.3% from $620M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Romano Brothers & Co's Q4 2022 filing shows 750 new, 84 increased, 162 reduced and 1 closed positions. Its largest new stake was Prologis: 3,336 shares worth $376K. The largest sale was Albemarle, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • Romano Brothers & Co's largest Q4 2022 buy was Prologis: 3,336 shares worth $376K.
  • Romano Brothers & Co added most to Generac Holdings in Q4 2022, an estimated $748K increase.
  • Romano Brothers & Co's biggest Q4 2022 reduction was Albemarle, cutting an estimated $10.3M.
  • Romano Brothers & Co fully exited Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q4 2022, selling an estimated $177K.
  • Romano Brothers & Co's ten largest holdings make up 20% of its $659M portfolio in Q4 2022.
  • Romano Brothers & Co opened 750 new positions and closed 1 in Q4 2022.
  • Romano Brothers & Co's portfolio value rose 6.3% quarter-over-quarter to $659M.

Based on Romano Brothers & Co's 13F filing for Q4 2022, filed 18 Jan 2023.